Cambrex Corporation (CBM): Price and Financial Metrics
CBM Stock Summary
- With a price/earnings ratio of 54.79, NA P/E ratio is greater than that of about 87.37% of stocks in our set with positive earnings.
- For CBM, its debt to operating expenses ratio is greater than that reported by 77.24% of US equities we're observing.
- With a year-over-year growth in debt of 62.65%, NA's debt growth rate surpasses 81.95% of about US stocks.
- If you're looking for stocks that are quantitatively similar to NA, a group of peers worth examining would be IOSP, JOUT, ISDR, CC, and MTSC.
CBM Stock Price Chart More Charts
CBM Price/Volume Stats
|Current price||$59.99||52-week high||$60.29|
|Prev. close||$59.99||52-week low||$33.80|
|Day high||$59.99||Avg. volume||425,060|
|50-day MA||$59.72||Dividend yield||N/A|
|200-day MA||$49.33||Market Cap||2.02B|
Cambrex Corporation (CBM) Company Bio
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The company was founded in 1981 and is based in East Rutherford, New Jersey.